Medtronic Company Overview

Transcription

1 Medtronic Company Overview

2 Creating Meaningful Change Together Together, Medtronic and Covidien are working to improve healthcare by addressing the needs of more people, in more ways, and in more places around the world. We brought our two companies together to accelerate and advance our ability to create meaningful innovations for hospitals, health systems, and healthcare providers so they can deliver the best care possible to patients and their families around the world. 2 Medtronic Confidential

3 Taking Our Mission Further As a combined company, we will continue on our journey to pursue our Mission. To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life. To direct our growth in the areas of biomedical engineering To strive without reserve for the greatest possible reliability To make a fair profit To recognize the personal worth of employees To maintain good citizenship 3 Medtronic Confidential

4 Making Business Solutions Human Solutions Medtronic s three key strategic priorities Therapy Innovation Introducing and delivering meaningful therapies and procedures Globalization Addressing the inequities in healthcare access globally Economic Value Helping lead the creation of value-based healthcare solutions 4 Medtronic Confidential

5 Serving Healthcare Systems Around the World 160+ Number of countries operating in Americas Greater China 85,000+ Employees Europe, Middle East, & Africa Asia Pacific 84 Manufacturing facilities 56 Research centers Medtronic is a multi-national company structured into four regions. 5 Medtronic Confidential

6 Connecting What We Do with What People Need CARDIAC RHYTHM Atrial fibrillation Slow heart rates (bradycardia) Fast heart rates (tachycardia) Heart failure Asymptomatic heart rates CARDIO THORACIC + Interventional lung + Lobectomy and lung resection CORONARY Coronary artery disease DIABETES Type 1/type 2 DIAGNOSTICS AND SOLUTIONS + CO 2 + Consciousness + Pulse oximetry + Skin integrity + Patient & caregiver safety EAR, NOSE, AND THROAT Sinus diseases Thyroid conditions Otologic disorders Sleep-disordered breathing Pediatric conditions Ménière s disease + Thyroidectomy + Airway and ventilation ENDOVASCULAR Aortic aneurysms Peripheral vascular disease + Arterial + Venous insufficiency + Deep vein thrombosis + End stage renal disease NEUROLOGICAL Severe spasticity Parkinson s disease Essential tremor Dystonia* Hydrocephalus Obsessive-compulsive disorder* Brain tumors and lesions Chronic pain Subdural hematomas Cranial trauma + Acute ischemic stroke + Brain aneurysm + Vascular embolization SPINAL AND ORTHOPEDIC Cervical degenerative disc disease Scoliosis Degenerative disc disease Spinal fracture Lumbar spinal stenosis Tibial fractures Orthopedic trauma STRUCTURAL HEART Heart valve disease Congenital heart disease UROLOGICAL, UROGYNECOLOGICAL, AND GASTROENTEROLOGICAL Overactive bladder and urinary retention Nausea and vomiting associated with gastroparesis* Fecal incontinence + Interventional GI + Cholecystectomy + Appendectomy + Barrett s esophagus + Capsule endoscopy + Hernia repair + Bariatric bypass and sleeves + Colon resection + Hemorrhoidectomy + Nutrition delivery + Hysterectomy, fibroids, and sterilization + Salpingo-oophorectomy Medtronic Covidien * Humanitarian device in the United States the effectiveness for this use has not been demonstrated 6 Medtronic Confidential

7 Shared Goals, Deeper Relationships We are excited to reach this agreement with Covidien, which further advances our Mission to alleviate pain, restore health, and extend life for patients around the world. This combination allows Medtronic to reach more people, in more ways, and in more places. Omar Ishrak Chairman and CEO of Medtronic Our expertise and portfolio of services allow us to serve our customers more efficiently and better address the demands of the current healthcare marketplace. We are pleased to welcome the Covidien team to Medtronic and together improve healthcare outcomes globally. 7 Medtronic Confidential

8 Appendix

9 Our Structure Cardiac and Vascular Group Diabetes Group Restorative Therapies Group Covidien Group Aortic & Peripheral Vascular Intensive Insulin Management Neuromodulation Early Technologies Cardiac Rhythm & Heart Failure Non-Intensive Diabetes Therapies Neurovascular Orthopedics Advanced Surgical Technologies and General Surgical Products Coronary & Structural Heart Diabetes Services and Solutions Spine Surgical Technologies Medical Supplies, Respiratory & Monitoring Solutions, and Venous Solutions 9 Medtronic Confidential

10 Our Leadership Omar Ishrak Chairman and Chief Executive Officer Mike Coyle EVP and Group President, Cardiac and Vascular Hooman Hakami EVP and Group President, Diabetes Bryan Hanson EVP and Group President, Covidien Chris O Connell EVP and Group President, Restorative Therapies Michael Genau SVP and President, Americas Chris Lee SVP and President, Greater China Rob ten Hoedt EVP and President, Europe, Middle East, and Africa Bob White SVP and President, Asia Pacific Gary Ellis EVP and Chief Financial Officer Rick Kuntz, M.D. SVP and Chief Scientific, Clinical, and Regulatory Officer Brad Lerman SVP, General Counsel and Corporate Secretary Geoff Martha SVP, Business Development and Strategy, and Chief Integration Officer Stephen Oesterle, M.D. SVP, Medicine and Technology Luann Pendy SVP, Global Quality Carol Surface SVP and Chief Human Resources Officer 10 Medtronic Confidential

11 Medtronic Facts and Stats Number of employees: 85,000+ Number of countries operating in: 160+ Number of patents: 53,000+ Research and development spend: $2B Charitable contributions: $80M Information reflects Medtronic fiscal year 2014 data and Covidien fiscal year 2014 data. 11 Medtronic Confidential